about
The microbiota shifts the iron sensing of intestinal cells.Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndromeRecent concepts concerning the renal handling of NH3/NH4+.Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coliHemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.Porphyrias: A 2015 update.Iron is a substrate of the Plasmodium falciparum chloroquine resistance transporter PfCRT in Xenopus oocytes.Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.Hepcidin regulates intrarenal iron handling at the distal nephron.Management of iron overload in hemoglobinopathies.Iron metabolism: State of the art.High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders.Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency.Mitochondrial energetic defects in muscle and brain of a Hmbs-/- mouse model of acute intermittent porphyria.Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation.Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice.Exploring the role of galectin 3 in kidney function: a genetic approach.Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease.Mutation in human CLPX elevates levels of δ-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria.Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation.A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.Porphyria and kidney diseases.Regulation by PKC isoforms of Na(+)/H(+) exchanger in luminal membrane vesicles isolated from cortical tubules.Dyserythropoiesis evaluated by RED score and hepcidin/ferritin levels predicts response to erythropoietin in lower risk myelodysplastic syndromesFunctional EPO-Hepcidin axis in Recombinant human EPO independent hemodialysis patientsHepatocellular carcinoma in acute hepatic porphyrias: A Damocles SwordAcute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse modelHigh urinary ferritin reflects myoglobin iron evacuation in DMD patientsProtein kinase C isoforms in rat kidney proximal tubule: acute effect of angiotensin II[Role of the Na(+)-K+(NH4+)-2Cl cotransporter of the medullary ascending limb in the regulation of renal acid-base equilibrium][Effect of angiotensin ii on Na+/H+ exchangers of the renal tubule]Regulation of ROMK (Kir 1.1) channel expression in kidney thick ascending limb by hypertonicity: role of TonEBP and MAPK pathwaysRenal handling of NH3/NH4+: recent conceptsZeta-crystallin mediates the acid pH-induced increase of BSC1 cotransporter mRNA stabilityProtoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse modelFrom a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyriaRecurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liverIron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up
P50
Q35775491-E9158CF2-C6D9-40E9-AA98-FD4A0534169DQ36296712-A57318F6-675F-4C6A-8808-BB4418111463Q36493422-1B75DA1D-BEC3-4DC3-B829-E50BE8C1F8E9Q36624644-8F0A3ECC-1CFF-4D63-9AA0-8E296B8304B9Q37618819-05391C20-3E0A-4808-A29A-72CB71CA6F73Q37693360-A5AEF6C2-36F6-412B-A08A-7BBE23777FC0Q38542777-357687BE-5845-4696-85E4-30387FA03356Q38646046-FFE791D3-B578-48C7-AF64-E7427E19B166Q38818590-E3365A7A-83A0-4A65-A8DD-2D4407B5BAC5Q39161145-A4B5C4D8-10D8-431E-91F1-56E900808816Q39412094-21DE96FE-06C0-4DED-826F-7C179A9CA2D7Q40140993-38C0AA7E-BF6C-409E-AA8A-31246C788964Q41129067-C167F0D6-552F-4CF4-89E3-5C1E17B99E33Q41203826-8BE2FFAF-F3A1-4854-9D08-9A54028AC2A2Q41480174-E7E237FB-A228-4146-B3F2-7FB42F98FFD3Q42478276-EC699FC8-4C47-41E8-BBBA-151CF901860AQ42906357-7FE51492-8436-45F1-B77D-4884DFB467C8Q44115012-4D0E55A0-959D-487E-9987-A180BFFB8F46Q46706379-E974CDB6-A803-450A-9E39-6B26FF71D54FQ47412147-AE546582-62DA-4CE1-8264-B39D2DD75D72Q47851870-085CEC42-768E-4412-B88A-69474DE71C93Q50529592-E8B70C1E-05B8-4048-AB26-C4E4A299BD43Q51229898-79A9F105-5025-4F70-A381-B2AD4E98A2D4Q52324266-CF085333-0F12-42D8-8441-54D467FEEC73Q54072280-2E2BB59D-C110-4E61-B110-F4F59B3CBF7AQ57027140-A7AAA676-C5E2-467A-9263-214860093488Q57161823-B6EEDCC1-91DA-4822-9772-029E163812E8Q58578906-F218996D-94B4-48CC-B2C9-03B6C04974D8Q59590280-D06BF600-2E48-42A6-B350-ABABE07B8DACQ62381824-7CCEE1F9-9F8B-4FE6-ADB0-1BED84E66459Q71949218-DD3E9CB2-A253-407C-85C5-3192E820E0DEQ74778645-D9B0CA23-656E-4C5E-B753-1BE889157F3CQ77698003-59EAA8B8-4BFF-407B-8EA3-B6777C2F60CAQ79144158-C22E4BD6-67D5-4401-AF87-46BA61698E99Q81093664-CB6A41AC-9625-4771-A861-7B8FA8467F03Q84354621-4965FE10-8CED-49D2-B859-F4FBE64DBF63Q84564481-91B38A9B-18C6-4AC4-9A48-CC954BE768BFQ87588017-49EB2163-8064-4D48-A79F-8D4219C4C0DEQ87937480-12123CCB-302B-4FEC-899A-6E0540FA50DAQ88093117-23684C94-9B02-4BC2-9974-198C6D8B0683
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zoubida Karim
@ast
Zoubida Karim
@en
Zoubida Karim
@es
Zoubida Karim
@fr
Zoubida Karim
@nl
type
label
Zoubida Karim
@ast
Zoubida Karim
@en
Zoubida Karim
@es
Zoubida Karim
@fr
Zoubida Karim
@nl
prefLabel
Zoubida Karim
@ast
Zoubida Karim
@en
Zoubida Karim
@es
Zoubida Karim
@fr
Zoubida Karim
@nl
P106
P21
P31
P496
0000-0002-3724-5592